Loading…

EP11.01-07 Low NLR Predicted Overall Survival Benefit of Pembrolizumab and Chemotherapy Combination in Patients with NSCLC and Low PD-L1 Expression

Saved in:
Bibliographic Details
Published in:Journal of thoracic oncology 2023-11, Vol.18 (11), p.S612
Main Authors: Chen, C.-W., Lin, C.-Y., Tsai, J.-S., Su, P.-L., Lin, C.-C.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1556-0864
DOI:10.1016/j.jtho.2023.09.1157